IOL Chemicals And Pharmaceuticals Ltd.
Snapshot View

324.70 -10.95 ▼-3.3%

27 January 2023, 04:01:00 PM
Volume: 32,731

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://iolcp.com
Market Cap 1,906.17 Cr.
Enterprise Value(EV) 1,932.68 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) 20.17 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) 16.10 Trailing Twelve Months Ending 2022-09
Industry PE 32.90 Trailing Twelve Months Ending 2022-09
Book Value / Share 245.30 Trailing Twelve Months Ending 2022-09
Price to Book Value 1.32 Calculated using Price: 324.70
Dividend Yield 1.23 Period Ending 2022-03
No. of Shares Subscribed 5.87 Cr. 58,705,502 Shares
FaceValue 10
Company Profile
IOL Chemicals and Pharmaceuticals (IOLCP) is a leading organic chemicals manufacturers and suppliers. They are Indian manufacturer of industrial chemicals & bulk drugs for over two decades, by pursuing & implementing the highest standards of excellence in their operations, they have nurtured their capabilities by delivering consistent results and have earned the admiration of customers and stakeholders alike.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-3.26%
1 Week
-4.32%
1 Month
-12.70%
3 Month
-10.22%
6 Month
-6.47%
1 Year
-23.93%
2 Year
-54.26%
5 Year
+319.78%
10 Year
+1225.31%
9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) 1.85 -34.14 -20.72 2.50 13.70 69.54 56.93 43.06 12.50
Return on Capital Employed (%) 11.48 -2.78 3.68 11.57 15.03 55.53 68.09 54.20 17.16
Return on Assets (%) 0.45 -9.24 -5.43 0.59 3.34 25.50 30.66 28.69 8.78

Balance Sheet View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 209 207 185 189 216 474 814 1,260 1,390 1,440
Non Curr. Liab. 255 286 304 294 280 211 80 59 57 57
Curr. Liab. 277 209 283 328 351 325 454 433 575 512
Minority Int.
Equity & Liab. 742 702 772 811 847 1,010 1,347 1,752 2,022 2,009
Non Curr. Assets 460 418 416 396 416 458 499 600 882 1,032
Curr. Assets 281 283 357 415 431 552 848 1,152 1,141 977
Misc. Exp. not W/O
Total Assets 742 702 772 811 847 1,010 1,347 1,752 2,022 2,009

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 564 385 580 711 983 1,685 1,894 1,967 2,184 2,234
Other Income 1 1 1 1 6 10 16 24 32 26
Total Income 565 386 582 712 990 1,696 1,910 1,991 2,216 2,260
Total Expenditure -468 -373 -529 -608 -864 -1,276 -1,321 -1,375 -1,928 -2,044
PBIDT 97 13 53 103 126 420 590 616 288 216
Interest -60 -59 -61 -68 -64 -51 -21 -6 -8 -12
Depreciation -32 -29 -30 -30 -30 -32 -36 -39 -43 -44
Taxation -2 9 -1 -1 -4 -99 -172 -127 -57 -42
Exceptional Items -14
PAT 3 -67 -40 5 28 237 361 445 166 118
Adjusted EPS 1 -14 -7 1 5 42 64 76 28 20

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 53 78 -47 18 83 120 273 471 380 91
Cash Fr. Inv. -18 -12 -5 -27 -23 -50 -63 -184 -317 -120
Cash Fr. Finan. -32 -66 50 9 -60 -70 -197 -272 -58 -2
Net Change 3 1 -2 0 1 -1 13 15 4 -31
Cash & Cash Eqvt 14 15 13 1 2 1 13 28 32 1

Shareholding Pattern View Details >>

9 Qtrs 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%)
Promoter 43.69 43.69 43.69 43.69 43.69 43.69 43.69 43.69 43.69
Public 56.31 56.31 56.31 56.31 56.31 56.31 56.31 56.31 56.31
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 20 Jan 2023
EUGMP Certification From National Institute Of Pharmacy And Nutrition Hungary
With reference to the Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we are pleased to inform that National Institute of Pharmacy and Nutrition Hungary has issued Certificate of GMP Compliance of Manufacturer for Companys products.
Fri, 20 Jan 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39 (3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015
Mon, 09 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Please find enclosed herewith a certificate received from M/s. Alankit Assignment Limited Registrar and Share Transfer Agent of the Company in compliance with the requirements of Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended 31st December 2022.

Technical Scans View Details >>

Fri, 27 Jan 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing Last Week Low Close Crossing Last Week Low
Close Crossing Last Month Low Close Crossing Last Month Low

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 249,710.79 1,040.75 +0.1%
Divi's Laboratories Ltd. 89,875.72 3,385.55 +1.5%
Cipla Ltd. 84,895.40 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. 71,960.69 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. 61,265.20 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. 52,047.83 1,537.85 -1.3%
Abbott India Ltd. 45,216.39 21,279.00 0.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.84 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 30.03 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-12 32.18 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 19.75 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 72.97 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 62.63 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 51.28 21,279.00 0.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.70 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-09 7.41 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-12 3.74 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-12 3.27 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 10.24 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-12 8.17 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-09 16.66 21,279.00 0.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.03 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 0.04 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 0.00 21,279.00 0.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 13.10 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 29.95 21,279.00 0.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 4,919.27 21,279.00 0.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,040.75 +0.1%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,385.55 +1.5%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,051.80 +1.7%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,321.35 +2.8%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,260.90 +0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,537.85 -1.3%
Abbott India Ltd. Standalone 2022-03 798.70 21,279.00 0.0%

FAQ's On IOL Chemicals And Pharmaceuticals Ltd.

What is IOL Chem & Pharma share price?

Can I buy IOL Chem & Pharma shares now?

What is the Dividend Yield of IOL Chem & Pharma?

What is the Market Cap of IOL Chem & Pharma?

What are the key metrics to analyse IOL Chem & Pharma?

What is the 52 Week High and Low of IOL Chem & Pharma?

What is the trend of IOL Chem & Pharma share price?